Theoretical context-sensitive elimination times for inhalation anaesthetics

British Journal of Anaesthesia

Volumn 104, Issue 5, 2010, Pages 648-655

  Lockwood, G ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

Biotransformation (drug), anaesthetics volatile; Model, pharmacokinetic; Recovery

Indexed keywords

DESFLURANE; ENFLURANE; FLUORIDE; HALOTHANE; INHALATION ANESTHETIC AGENT; ISOFLURANE; NITROUS OXIDE; SEVOFLURANE; XENON;

ADIPOSE TISSUE; ARTICLE; COMPARTMENT MODEL; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG BRAIN LEVEL; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG LIVER LEVEL; DRUG METABOLISM; DRUG MUSCLE LEVEL; DRUG TISSUE LEVEL; DRUG UPTAKE; PREDICTION; PRESSURE; PRIORITY JOURNAL; TREATMENT DURATION; VALIDATION STUDY;

EID: 77951291385     PISSN: 00070912     EISSN: 14716771     Source Type: Journal    
DOI: 10.1093/bja/aeq051     Document Type: Article

References (23)

1. Bailey JM. Context-sensitive half-times and other decrement times of inhaled anesthetics. Anesth Analg 1997; 85: 681-686
2. Knill RL, Gelb AW. Ventilatory responses to hypoxia and hypercapnia during halothane sedation and anesthesia in man. Anesthesiology 1978; 49: 244-251
3. Yasuda N, Lockhart SH, Eger EI, et al. Kinetics of desflurane, isoflurane, and halothane in humans. Anesthesiology 1991; 74: 489-498
4. Fiserova-Bergerova V. Extrapolation of physiological parameters for physiologically based simulation models. Toxicol Lett 1995; 79: 77-86
5. Zhou JX, Liu J. The effect of temperature on solubility of volatile anesthetics in human tissues. Anesth Analg 2001; 93: 234-238
6. Park-Holohan SJ, Blake GM, Fogelman I. Quantitative studies of bone using 18F-fluoride and 99mTc-methylene diphosphonate: evaluation of renal and whole-blood kinetics. Nucl Med Commun 2001; 22: 1037-1044
7. Cahalan MK, Johnson BH, Eger EI, et al. A noninvasive in vivo method of assessing the kinetics of halothane metabolism in humans. Anesthesiology 1982; 57: 298-302
8. Spracklin DK, Hankins DC, Fisher JM, Thummel KE, Kharasch ED. Cytochrome P450 2E1 is the principal catalyst of human oxidative halothane metabolism in vitro. J Pharmacol Exp Ther 1997; 281: 400-411
9. Barter ZE, Chowdry JE, Harlow JR, Snawder JE, Lipscomb JC, Rostami-Hodjegan A. Covariation of human microsomal protein per gram of liver with age: absence of influence of operator and sample storage may justify interlaboratory data pooling. Drug Metab Dispos 2008; 36: 2405-2409
10. Carpenter RL, Eger EI, Johnson BH, Unadkat JD, Sheiner LB. Pharmacokinetics of inhaled anesthetics in humans: measurements during and after the simultaneous administration of enflurane, halothane, isoflurane, methoxyflurane, and nitrous oxide. Anesth Analg 1986; 65: 575-582
11. Yasuda N, Lockhart SH, Eger EI, et al. Comparison of kinetics of sevoflurane and isoflurane in humans. Anesth Analg 1991; 72: 316-324
12. Mapleson WW. Effect of age on MAC in humans: a meta-analysis. Br J Anaesth 1996; 76: 179-185
13. Mazze RI, Calverley RK, Smith NT. Inorganic fluoride nephrotoxicity: prolonged enflurane and halothane anesthesia in volunteers. Anesthesiology 1977; 46: 265-271
14. Hitt BA, Mazze RI, Beppu WJ, Stevens WC, Eger EI. Enflurane metabolism in rats and man. J Pharmacol Exp Ther 1977; 203: 193-202
15. Laisalmi M, Soikkeli A, Kokki H, et al. Fluoride metabolism in smokers and non-smokers following enflurane anaesthesia. Br J Anaesth 2003; 91: 800-804
16. Bentley JB, Vaughan RW, Miller MS, Calkins JM, Gandolfi AJ. Serum inorganic fluoride levels in obese patients during and after enflurane anesthesia. Anesth Analg 1979; 58: 409-412
17. Eger EI, Gong D, Koblin DD, et al. Dose-related biochemical markers of renal injury after sevoflurane versus desflurane anesthesia in volunteers. Anesth Analg 1997; 85: 1154-1163
18. Kharasch ED, Armstrong AS, Gunn K, Artru A, Cox K, Karol MD. Clinical sevoflurane metabolism and disposition. II. The role of cytochrome P450 2E1 in fluoride and hexafluoroisopropanol formation. Anesthesiology 1995; 82: 1379-1388
19. Shiraishi Y, Ikeda K. Uptake and biotransformation of sevoflurane in humans: a comparative study of sevoflurane with halothane, enflurane, and isoflurane. J Clin Anesth 1990; 2: 381-386
20. Higuchi H, Sumita S, Wada H, et al. Effects of sevoflurane and isoflurane on renal function and on possible markers of nephrotoxicity. Anesthesiology 1998; 89: 307-322
21. Nishiyama T, Hanaoka K. Inorganic fluoride kinetics and renal and hepatic function after repeated sevoflurane anesthesia. Anesth Analg 1998; 87: 468-473
22. Ekstrand J, Ehrnebo M, Whitford GM, Järnberg PO. Fluoride pharmacokinetics during acid-base balance changes in man. Eur J Clin Pharmacol 1980; 18: 189-194
23. Press W, Flannery B, Teukolsy S, Vetterling W. Numerical Recipes in Pascal. Cambridge: Cambridge University Press, 1989